**Author details**

Omar S. Aljitawi University of Rochester Medical Center, Rochester, NY, USA

\*Address all correspondence to: omar\_aljitawi@urmc.rochester.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**161**

*Effect of Hyperbaric Oxygen on Hematopoietic Stem Cell Transplantation*

children and adults. Bone Marrow Transplantation. 2001;**27**(1):1-6

[9] Johansen KA, Schneider JF, McCaffree MA, Woods GL. Efforts of the United States' National Marrow Donor Program and registry to improve utilization and representation of minority donors. Transfusion Medicine.

[10] Milano F, Gooley T, Wood B, Woolfrey A, Flowers ME, Doney K, et al. Cord-blood transplantation in patients with minimal residual disease. The New England Journal of Medicine.

[11] Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor

cell content is a better predictor than nucleated cell quantity. Blood.

[12] Szabolcs P, Niedzwiecki D. Immune reconstitution after unrelated cord blood transplantation. Cytotherapy.

[13] Brown JA, Boussiotis VA. Umbilical cord blood transplantation: Basic biology and clinical challenges to immune reconstitution. Clinical Immunology. 2008;**127**(3):286-297

[14] Komanduri KV, St John LS, de Lima M, McMannis J, Rosinski S, McNiece I, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood. 2007;**110**(13):4543-4551

[15] Szabolcs P, Cairo MS. Unrelated umbilical cord blood transplantation and immune reconstitution. Seminars in

Hematology. 2010;**47**(1):22-36

2008;**18**(4):250-259

2016;**375**(10):944-953

2000;**96**(8):2717-2722

2007;**9**(2):111-122

*DOI: http://dx.doi.org/10.5772/intechopen.85223*

[1] Barker JN, Wagner JE. Umbilicalcord blood transplantation for the treatment of cancer. Nature Reviews.

[2] Barker JN, Byam CE, Kernan NA, Lee SS, Hawke RM, Doshi KA, et al. Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation. 2010;**16**(11):1541-1548

[3] Ruggeri A, Ciceri F, Gluckman E, Labopin M, Rocha V. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors? Best Practice & Research. Clinical Haematology.

2010;**23**(2):207-216

[4] Gluckman E, Broxmeyer HA, Auerbach AD, Friedman HS, Douglas GW, Devergie A, et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLAidentical sibling. The New England Journal of Medicine. 1989;**321**(17):1174-1178

[5] Ballen KK, Gluckman E,

Broxmeyer HE. Umbilical cord blood transplantation: The first 25 years and beyond. Blood. 25 Jul 2013;**122**(4): 491-498. DOI: 10.1182/blood-2013- 02-453175. [Epub: 14 May 2013]

[6] Ruggeri A. Alternative donors: Cord blood for adults. Seminars in Hematology. 2016;**53**(2):65-73

[7] Gluckman E. History of cord blood transplantation. Bone Marrow Transplantation. 2009;**44**(10):621-626

[8] Laughlin MJ. Umbilical cord blood for allogeneic transplantation in

Cancer. 2003;**3**(7):526-532

**References**

*Effect of Hyperbaric Oxygen on Hematopoietic Stem Cell Transplantation DOI: http://dx.doi.org/10.5772/intechopen.85223*
